Fritextsökning
Innehållstyper
-
Swedish nanotech crosses the Atlantic
Genovis signs distribution agreement Finnzymes in US.
-
Pharma is a safe market
Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...
-
New influenza vaccine to EU
The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...
-
Tio minuters trädgårdsarbete räcker
Så lite som tio minuters motion per vecka ser ut att minska risken för hjärtdöd, enligt en kinesisk observationsstudie.
-
Swedish cancer therapy granted
Pledpharma, Linköping University and Ryhov County Hospital receive a research grant from the Research Council FORSS to conduct clinical studies in cancer patients.
-
Uppsala i toppen när inkubatorer rankas
Uppsala innovation centre har rankats som världens fjärde bästa företagsinkubator med universitetskoppling.
-
Nytt bolag i hubben
Bioteknikbolaget Cereno Scientific är det senaste företaget som tar plats i Astrazenecas Bio Venture Hub.
-
Crafoord Prize to an American and two Japanese
Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.
-
Ny teknik kan upptäcka alzheimer tidigare
Detektion av specifika former av proteinet tau i blodprover kan ge tidigare diagnostik av personer med alzheimer, redan innan de första symptomen uppstår.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Samuel Lagercrantz: Framgången kommer efter många misslyckanden
De allra flesta av de idéer och strategier mot covid-19 som man nu jobbar med kommer att gå i stöpet, men det kan räcka med att en enda fungerar, skriver Samuel Lagercrantz.
-
EU grants project on toxicity of nanomaterials
A multinational research project has have been awarded EUR 3 358 500 from the European Commission to study the hazardous effects of engineered nanomaterials on ...
-
Dako appoints new CEO
The Danish cancer therapeutic company Dako has appointed a new CEO after Patrik Dahlén.
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
Medicon Valley cluster in brief
The Medicon Valley covers the Öresund region (Skåne and Sjaelland).
-
Hitflyttade ska sälja Sverige
Internationella nyckelpersoner hyllar Sverige som life science-nation i slutfasen av EMA-striden.
-
Grönt ljus för Hamlet – startar klinisk studie
Fritt fram för klinisk studie med bröstmjölksprotein mot blåscancer.
-
Seminar program Biotech Forum
Here is the entire seminar program at Biotech Forum September 28-29th
-
New study of toxins and heart disease
Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study...
-
Higher performance UV-Vis spectrophotometry with double beams
The Biochrom Libra series of UV-Vis spectrophotometers now features double beams and variable bandwidths.
-
Lund honours milieu enthusiast
Four professors at the University of Lund has appointed the milieu chief of the university as honorary doctor.
-
Tom Britton: ”Nivån för flockimmunitet är lägre än vad vi trott”
Nya matematiska modeller pekar på att flockimmunitetsnivån är kraftigt lägre än vad man tidigare trott, och att immuniteten i dagsläget spelar en större roll, e...
BREAKING